Henatinib is an Orally Active Multikinase Inhibitor with Broad Antitumor Activities
Tumor growth and development involve many complex pathways, such as malignant cell proliferation and angiogenesis. Kinases are the enzymes that control signal transduction in these pathways, including VEGF, PDGFR, c-kit, and…